These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9810213)

  • 21. Erythropoietin and analogs.
    Reichel C; Gmeiner G
    Handb Exp Pharmacol; 2010; (195):251-94. PubMed ID: 20020369
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Erythropoietin use and abuse: When physiology and pharmacology collide.
    Spivak JL
    Adv Exp Med Biol; 2001; 502():207-24. PubMed ID: 11950139
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin in athletes. Blood sampling and doping control.
    Souillard A; Audran M; Bressolle F; Gareau R; Duvallet A; Chanal JL
    Br J Clin Pharmacol; 1996 Sep; 42(3):355-64. PubMed ID: 8877027
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect of altitude on second-generation blood tests to detect erythropoietin abuse by athletes.
    Ashenden MJ; Gore CJ; Parisotto R; Sharpe K; Hopkins WG; Hahn AG
    Haematologica; 2003 Sep; 88(9):1053-62. PubMed ID: 12969814
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Ongoing medical problems in the anti-doping fight].
    Delagardelle C; Ries F; Feiereisen P; Urhausen A
    Bull Soc Sci Med Grand Duche Luxemb; 2007; (2):109-24. PubMed ID: 18084907
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of reference ranges in elite athletes for markers of altered erythropoiesis.
    Sharpe K; Hopkins W; Emslie KR; Howe C; Trout GJ; Kazlauskas R; Ashenden MJ; Gore CJ; Parisotto R; Hahn AG
    Haematologica; 2002 Dec; 87(12):1248-57. PubMed ID: 12495898
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Sports doping: Racing just to keep up.
    Callaway E
    Nature; 2011 Jul; 475(7356):283-5. PubMed ID: 21776058
    [No Abstract]   [Full Text] [Related]  

  • 28. Blood doping: risks to athletes' health and strategies for detection.
    Oliveira CD; Bairros AV; Yonamine M
    Subst Use Misuse; 2014 Jul; 49(9):1168-81. PubMed ID: 24766400
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Testing for recombinant erythropoietin.
    Delanghe JR; Bollen M; Beullens M
    Am J Hematol; 2008 Mar; 83(3):237-41. PubMed ID: 17918255
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Erythropoietin abuse and erythropoietin gene doping: detection strategies in the genomic era.
    Diamanti-Kandarakis E; Konstantinopoulos PA; Papailiou J; Kandarakis SA; Andreopoulos A; Sykiotis GP
    Sports Med; 2005; 35(10):831-40. PubMed ID: 16180943
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Doping in the recombinant era: strategies and counterstrategies.
    Azzazy HM; Mansour MM; Christenson RH
    Clin Biochem; 2005 Nov; 38(11):959-65. PubMed ID: 16286094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Erythropoietin in sports: a new look at an old problem.
    Scott J; Phillips GC
    Curr Sports Med Rep; 2005 Aug; 4(4):224-6. PubMed ID: 16004833
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Drugs for increasing oxygen and their potential use in doping: a review.
    Gaudard A; Varlet-Marie E; Bressolle F; Audran M
    Sports Med; 2003; 33(3):187-212. PubMed ID: 12656640
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An integrative 'omics' solution to the detection of recombinant human erythropoietin and blood doping.
    Pitsiladis YP; Durussel J; Rabin O
    Br J Sports Med; 2014 May; 48(10):856-61. PubMed ID: 24627340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gene doping detection: evaluation of approach for direct detection of gene transfer using erythropoietin as a model system.
    Baoutina A; Coldham T; Bains GS; Emslie KR
    Gene Ther; 2010 Aug; 17(8):1022-32. PubMed ID: 20463760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bayesian detection of abnormal hematological values to introduce a no-start rule for heterogeneous populations of athletes.
    Robinson N; Sottas PE; Mangin P; Saugy M
    Haematologica; 2007 Aug; 92(8):1143-4. PubMed ID: 17650448
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of intermittent hypoxia on hematological parameters after recombinant human erythropoietin administration.
    Sanchis-Gomar F; Martinez-Bello VE; Domenech E; Nascimento AL; Pallardo FV; Gomez-Cabrera MC; Vina J
    Eur J Appl Physiol; 2009 Nov; 107(4):429-36. PubMed ID: 19669157
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Artificial oxygen carriers--the new doping threat in endurance sport?
    Schumacher YO; Schmid A; Dinkelmann S; Berg A; Northoff H
    Int J Sports Med; 2001 Nov; 22(8):566-71. PubMed ID: 11719891
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Medicine and science in the fight against doping in sport.
    Catlin DH; Fitch KD; Ljungqvist A
    J Intern Med; 2008 Aug; 264(2):99-114. PubMed ID: 18702750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hemoglobin and packed-cell volume in endurance athletes prior to rhEPO.
    Kujala UM; Peltonen JE; Elovainio RO
    Int J Sports Med; 2000 Apr; 21(3):228-30. PubMed ID: 10834359
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.